ANO1: More Than Just Calcium-Activated Chloride Channel in Cancer.
ANO1
cancer
inhibitor
miRNA
protein network
signal pathway
tumor microenvironment
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
18
04
2022
accepted:
09
05
2022
entrez:
23
6
2022
pubmed:
24
6
2022
medline:
24
6
2022
Statut:
epublish
Résumé
ANO1, a calcium-activated chloride channel (CACC), is also known as transmembrane protein 16A (TMEM16A). It plays a vital role in the occurrence, development, metastasis, proliferation, and apoptosis of various malignant tumors. This article reviews the mechanism of ANO1 involved in the replication, proliferation, invasion and apoptosis of various malignant tumors. Various molecules and Stimuli control the expression of ANO1, and the regulatory mechanism of ANO1 is different in tumor cells. To explore the mechanism of ANO1 overexpression and activation of tumor cells by studying the different effects of ANO1. Current studies have shown that ANO1 expression is controlled by 11q13 gene amplification and may also exert cell-specific effects through its interconnected protein network, phosphorylation of different kinases, and signaling pathways. At the same time, ANO1 also resists tumor apoptosis and promotes tumor immune escape. ANO1 can be used as a promising biomarker for detecting certain malignant tumors. Further studies on the channels and the mechanism of protein activity of ANO1 are needed. Finally, the latest inhibitors of ANO1 are summarized, which provides the research direction for the tumor-promoting mechanism of ANO1.
Identifiants
pubmed: 35734591
doi: 10.3389/fonc.2022.922838
pmc: PMC9207239
doi:
Types de publication
Systematic Review
Langues
eng
Pagination
922838Informations de copyright
Copyright © 2022 Guo, Zhang and Li.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Cancers (Basel). 2021 Mar 09;13(5):
pubmed: 33803266
Sci Rep. 2015 Nov 13;5:16657
pubmed: 26563938
Oncotarget. 2015 May 10;6(13):11585-99
pubmed: 25839162
Oncol Rep. 2016 Dec;36(6):3225-3232
pubmed: 27779716
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Trends Biochem Sci. 2015 Sep;40(9):535-43
pubmed: 26254230
Tumour Biol. 2013 Aug;34(4):2205-14
pubmed: 23564482
Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10376-81
pubmed: 22685202
Anticancer Res. 2019 Jul;39(7):3433-3442
pubmed: 31262867
J Clin Med. 2018 Dec 01;7(12):
pubmed: 30513772
J Biol Chem. 2021 Sep;297(3):101016
pubmed: 34329684
Pflugers Arch. 2020 Oct;472(10):1457-1467
pubmed: 32683500
Int J Cancer. 2019 May 1;144(9):2215-2226
pubmed: 30243029
Cancer Sci. 2018 Sep;109(9):2781-2791
pubmed: 29949674
Philos Trans R Soc Lond B Biol Sci. 2014 Feb 03;369(1638):20130096
pubmed: 24493744
Br J Cancer. 2010 Aug 24;103(5):715-26
pubmed: 20664600
Eur J Med Chem. 2018 Dec 5;160:245-255
pubmed: 30347323
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):13026-13035
pubmed: 31182586
Biomed Pharmacother. 2016 Dec;84:1113-1118
pubmed: 27780140
Biochim Biophys Acta. 2014 Oct;1843(10):2150-63
pubmed: 24440275
J Exp Clin Cancer Res. 2016 Mar 10;35:43
pubmed: 26964533
Elife. 2017 May 31;6:
pubmed: 28561733
Pflugers Arch. 2015 Jul;467(7):1495-1508
pubmed: 25163766
Mol Med Rep. 2014 Mar;9(3):1068-74
pubmed: 24401903
Cell Signal. 2002 Aug;14(8):649-54
pubmed: 12020764
PLoS One. 2015 May 11;10(5):e0126128
pubmed: 25961581
Int J Mol Sci. 2021 Nov 07;22(21):
pubmed: 34769467
Cancer Lett. 2019 Jul 28;455:48-59
pubmed: 31042586
Biochem Biophys Res Commun. 2012 Oct 19;427(2):248-53
pubmed: 22995309
Cancer Cell. 2012 Sep 11;22(3):304-17
pubmed: 22975374
J Cell Physiol. 2019 Jun;234(6):8698-8708
pubmed: 30370542
Adv Exp Med Biol. 2017;966:1-14
pubmed: 28293832
Int J Clin Oncol. 2020 Jun;25(6):1145-1154
pubmed: 32240440
Trends Cell Biol. 2013 Dec;23(12):620-33
pubmed: 23958396
PLoS One. 2012;7(8):e43265
pubmed: 22912841
Science. 2008 Oct 24;322(5901):590-4
pubmed: 18772398
Sci Rep. 2017 Nov 9;7(1):15173
pubmed: 29123240
Biochim Biophys Acta Mol Basis Dis. 2022 Jun 1;1868(6):166370
pubmed: 35231545
Lancet Oncol. 2013 May;14(6):e218-28
pubmed: 23639322
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):E1026-34
pubmed: 23431153
Sci Rep. 2016 May 23;6:26413
pubmed: 27212225
Molecules. 2020 Nov 06;25(21):
pubmed: 33172169
Pharmacol Res. 2020 Jun;156:104763
pubmed: 32201246
Exp Lung Res. 2014 Jun;40(5):237-50
pubmed: 24784799
PLoS One. 2016 May 24;11(5):e0155771
pubmed: 27219012
Eur J Med Chem. 2020 Dec 15;208:112688
pubmed: 32906067
PLoS One. 2015 Aug 25;10(8):e0136584
pubmed: 26305547
Pflugers Arch. 2016 Mar;468(3):443-53
pubmed: 26811235
J Gen Physiol. 2014 Jun;143(6):703-18
pubmed: 24863931
Cancer Genet. 2019 Feb;231-232:22-31
pubmed: 30803553
JCI Insight. 2020 Nov 19;5(22):
pubmed: 33048845
Clin Cancer Res. 2013 Nov 1;19(21):5867-78
pubmed: 24009147
Cancer Res. 2012 Jul 1;72(13):3270-81
pubmed: 22564524
PLoS One. 2017 Mar 31;12(3):e0174935
pubmed: 28362855
Ann Surg Oncol. 2016 Dec;23(Suppl 5):599-608
pubmed: 26868958
PLoS One. 2016 Jan 25;11(1):e0147409
pubmed: 26808319
Carcinogenesis. 2019 Oct 16;40(10):1198-1208
pubmed: 31050728
Cell. 2008 Sep 19;134(6):1019-29
pubmed: 18805094
Pancreas. 2016 Oct;45(9):1263-1271
pubmed: 27776045
Int J Mol Sci. 2021 Jul 01;22(13):
pubmed: 34281152
Physiol Rev. 2014 Apr;94(2):419-59
pubmed: 24692353
PLoS One. 2014 Dec 26;9(12):e115443
pubmed: 25541940
Cancer Cell. 2012 Sep 11;22(3):318-30
pubmed: 22975375
J Exp Clin Cancer Res. 2017 Feb 13;36(1):29
pubmed: 28193228
Clin Cancer Res. 2017 Dec 1;23(23):7324-7332
pubmed: 28899969
J Biol Chem. 2009 Nov 27;284(48):33360-8
pubmed: 19819874
Cell Death Dis. 2018 Jun 13;9(6):703
pubmed: 29899325
Onco Targets Ther. 2016 Jan 14;9:325-33
pubmed: 26834491
Cancer Lett. 2012 Dec 29;326(1):41-51
pubmed: 22820160
Cancers (Basel). 2019 Mar 19;11(3):
pubmed: 30893776
Cell. 2001 Feb 23;104(4):487-501
pubmed: 11239407
Pflugers Arch. 2016 Jul;468(7):1241-1257
pubmed: 27138167
PLoS One. 2015 Jul 21;10(7):e0133656
pubmed: 26196390
Arch Iran Med. 2019 Jan 01;22(1):32-38
pubmed: 30821158
Mol Hum Reprod. 1998 Dec;4(12):1099-109
pubmed: 9872359
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2523-31
pubmed: 25546839
Cancer Med. 2014 Jun;3(3):453-61
pubmed: 24639373
Oncotarget. 2015 Apr 20;6(11):9173-88
pubmed: 25823819
Oncol Rep. 2016 Dec;36(6):3371-3378
pubmed: 27779704
Bioessays. 2000 Aug;22(8):697-707
pubmed: 10918300
Oncotarget. 2016 Nov 29;7(48):78619-78630
pubmed: 27732935
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9722-7
pubmed: 26153424
Oncotarget. 2017 Jun 27;8(49):84996-85013
pubmed: 29156699
Mol Cancer. 2017 Sep 11;16(1):152
pubmed: 28893247
Pharmacol Res. 2020 May;155:104721
pubmed: 32097750
Oncol Rep. 2019 Apr;41(4):2361-2370
pubmed: 30816505
Biochim Biophys Acta Mol Cell Res. 2021 Nov;1868(12):119132
pubmed: 34450215